Effects of a Novel ACE Inhibitor, 3-(3-thienyl)-l-alanyl-ornithyl-proline, on Endothelial Vasodilation and Hepatotoxicity in L-NAME-induced Hypertensive Rats

Overview

Journal Drug Des Devel Ther

Specialty Pharmacology

Date 2016 May 5

PMID 27143859

Citations 6

Authors

Mahesh Kumar Seth

M Ejaz Hussain

Santosh Pasha

Mohammad Fahim

Affiliations

Soon will be listed here.

Abstract

Nitric oxide (NO) is a widespread biological mediator involved in many physiological and pathological processes, eg, in the regulation of vascular tone and hypertension. Chronic inhibition of NO synthase by N(G)-nitro-l-arginine methyl ester (l-NAME) hydrochloride results in the development of hypertension accompanied by an increase in vascular responsiveness to adrenergic stimuli. Recently, we developed a novel sulfur-containing angiotensin-converting enzyme inhibitor: 3-(3-thienyl)-l-alanyl-ornithyl-proline (TOP). Our previous studies indicated a superior nature of the molecule as an antihypertensive agent in spontaneously hypertensive rats (showing the involvement of renin-angiotensin-aldosterone system) in comparison to captopril. The aim of the present study was to investigate the effect of TOP on NO pathway in l-NAME-induced hypertensive rats, and captopril was included as the standard treatment group. Treatment with both TOP (20 mg/kg) and captopril (40 mg/kg) prevented the development of hypertension in l-NAME model, but TOP showed better restoration of NO and normal levels of angiotensin-converting enzyme. In addition, in vitro vasorelaxation assay showed an improvement in endothelium-dependent vasodilation in both the cases. Further, the biochemical (malondialdehyde, alanine aminotransferase, and aspartate aminotransferase) and the histopathological effects of TOP on rat liver tissues revealed a protective nature of TOP in comparison to captopril in the l-NAME model. In conclusion, TOP at 50% lesser dose than captopril was found to be better in the l-NAME model.

Citing Articles

The role of Kolaviron, a bioflavonoid from , in the management of cardiovascular diseases: A systematic review.

Olatoye F, Akindele A, Awodele O Heliyon. 2024; 10(5):e27333.

PMID: 38449600 PMC: 10915569. DOI: 10.1016/j.heliyon.2024.e27333.

Potential antihypertensive activity of novel peptides from green basil leaves.

Prangthip P, Panbangred W, Reamtong O BMC Complement Med Ther. 2023; 23(1):282.

PMID: 37553559 PMC: 10410819. DOI: 10.1186/s12906-023-04098-2.

Involvement of shedding induced by ADAM17 on the nitric oxide pathway in hypertension.

da Silva M, Dos Santos V, da Silva M, Prazeres T, Cartagenes M, Calzerra N Front Mol Biosci. 2022; 9:1032177.

PMID: 36310604 PMC: 9614329. DOI: 10.3389/fmolb.2022.1032177.

A Comparative Study of the Antihypertensive and Cardioprotective Potentials of Hot and Cold Aqueous Extracts of L. in Relation to Their Metabolic Profiles.

Salem M, Ezzat S, Ahmed K, Alseekh S, Fernie A, Essam R Front Pharmacol. 2022; 13:840478.

PMID: 35281911 PMC: 8905494. DOI: 10.3389/fphar.2022.840478.

Butterfly Pea Flower ( Linn.) Extract Ameliorates Cardiovascular Dysfunction and Oxidative Stress in Nitric Oxide-Deficient Hypertensive Rats.

Maneesai P, Iampanichakul M, Chaihongsa N, Poasakate A, Potue P, Rattanakanokchai S Antioxidants (Basel). 2021; 10(4).

PMID: 33801631 PMC: 8065438. DOI: 10.3390/antiox10040523.

References

Nava E, Farre A, Moreno C, Casado S, Moreau P, Cosentino F . Alterations to the nitric oxide pathway in the spontaneously hypertensive rat. J Hypertens. 1998; 16(5):609-15. DOI: 10.1097/00004872-199816050-00008. View

Maxwell A, Schauble E, Bernstein D, Cooke J . Limb blood flow during exercise is dependent on nitric oxide. Circulation. 1998; 98(4):369-74. DOI: 10.1161/01.cir.98.4.369. View

Romero J, Reckelhoff J . State-of-the-Art lecture. Role of angiotensin and oxidative stress in essential hypertension. Hypertension. 1999; 34(4 Pt 2):943-9. DOI: 10.1161/01.hyp.34.4.943. View

Nabha L, Garbern J, Buller C, Charpie J . Vascular oxidative stress precedes high blood pressure in spontaneously hypertensive rats. Clin Exp Hypertens. 2005; 27(1):71-82. DOI: 10.1081/ceh-200044267. View

Ozguner F, Oktem F, Ayata A, Koyu A, Yilmaz H . A novel antioxidant agent caffeic acid phenethyl ester prevents long-term mobile phone exposure-induced renal impairment in rat. Prognostic value of malondialdehyde, N-acetyl-beta-D-glucosaminidase and nitric oxide determination. Mol Cell Biochem. 2005; 277(1-2):73-80. DOI: 10.1007/s11010-005-5074-9. View

Khattab M, Mostafa A, Al-Shabanah O . Effects of captopril on cardiac and renal damage, and metabolic alterations in the nitric oxide-deficient hypertensive rat. Kidney Blood Press Res. 2005; 28(4):243-50. DOI: 10.1159/000088829. View

Kopkan L, Majid D . Enhanced superoxide activity modulates renal function in NO-deficient hypertensive rats. Hypertension. 2006; 47(3):568-72. DOI: 10.1161/01.HYP.0000200027.34925.93. View

Pavar M, Hanif K, Azam A, Lata S, Pasha M, Pasha S . Structure-activity relationship study between Ornithyl-Proline and Lysyl-Proline based tripeptidomimics as angiotensin-converting enzyme inhibitors. Bioorg Med Chem Lett. 2006; 16(8):2117-21. DOI: 10.1016/j.bmcl.2006.01.061. View

Gokcimen A, Kocak A, Kilbas S, Bayram D, Kilbas A, Cim A . Effect of lisinopril on rat liver tissues in L-NAME induced hypertension model. Mol Cell Biochem. 2006; 296(1-2):159-64. DOI: 10.1007/s11010-006-9310-8. View

10.

Zicha J, Dobesova Z, Kunes J . Antihypertensive mechanisms of chronic captopril or N-acetylcysteine treatment in L-NAME hypertensive rats. Hypertens Res. 2007; 29(12):1021-7. DOI: 10.1291/hypres.29.1021. View

11.

Pechanova O, Zicha J, Paulis L, Zenebe W, Dobesova Z, Kojsova S . The effect of N-acetylcysteine and melatonin in adult spontaneously hypertensive rats with established hypertension. Eur J Pharmacol. 2007; 561(1-3):129-36. DOI: 10.1016/j.ejphar.2007.01.035. View

12.

Kobori H, Nangaku M, Navar L, Nishiyama A . The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev. 2007; 59(3):251-87. DOI: 10.1124/pr.59.3.3. View

13.

Macarthur H, Westfall T, Wilken G . Oxidative stress attenuates NO-induced modulation of sympathetic neurotransmission in the mesenteric arterial bed of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol. 2007; 294(1):H183-9. DOI: 10.1152/ajpheart.01040.2007. View

14.

Bader M, Ganten D . Update on tissue renin-angiotensin systems. J Mol Med (Berl). 2008; 86(6):615-21. DOI: 10.1007/s00109-008-0336-0. View

15.

Torok J . Participation of nitric oxide in different models of experimental hypertension. Physiol Res. 2009; 57(6):813-825. DOI: 10.33549/physiolres.931581. View

16.

Hanif K, Snehlata , Pavar M, Arif E, Biswas P, Fahim M . Effect of 3-thienylalanine-ornithine-proline, new sulfur-containing angiotensin-converting enzyme inhibitor on blood pressure and oxidative stress in spontaneously hypertensive rats. J Cardiovasc Pharmacol. 2009; 53(2):145-50. DOI: 10.1097/FJC.0b013e318197c616. View

17.

Erdos E, Tan F, Skidgel R . Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function. Hypertension. 2010; 55(2):214-20. PMC: 2814794. DOI: 10.1161/HYPERTENSIONAHA.109.144600. View

18.

Vats I, Snehlata , Nath M, Pasha M, Pasha S . Effect of chronic intra-peritoneally administered chimeric peptide of met-enkephalin and FMRFa-[D-Ala2]YFa-on antinociception and opioid receptor regulation. Eur J Pain. 2009; 14(3):295.e1-9. DOI: 10.1016/j.ejpain.2009.05.014. View

19.

Oktem F, Kirbas A, Armagan A, Kuybulu A, Yilmaz H, Ozguner F . Lisinopril attenuates renal oxidative injury in L-NAME-induced hypertensive rats. Mol Cell Biochem. 2011; 352(1-2):247-53. DOI: 10.1007/s11010-011-0760-2. View

20.

Dabire H, Barthelemy I, Blanchard-Gutton N, Sambin L, Carlos Sampedrano C, Gouni V . Vascular endothelial dysfunction in Duchenne muscular dystrophy is restored by bradykinin through upregulation of eNOS and nNOS. Basic Res Cardiol. 2011; 107(1):240. PMC: 3358670. DOI: 10.1007/s00395-011-0240-6. View